Shareholding for the Period Ended March 31, 2018
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here07-04-2018
Shareholding for the Period Ended March 31, 2018
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click hereStatement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- DHAVAL N SONIDesignation :- Company Secretary and Compliance OfficerThe Company Shall Submit The Audited Financial Results For The Year Ended On March 31, 2018 Within 60 Days From The End Of The Financial Year.
The Company shall submit the audited financial results for the year ended on March 31, 2018 within 60 days from the end of the financial year.Compliance Certificate For The Half Year Ended On March 31, 2018.
Compliance Certificate for the Half Year ended on March 31, 2018.Zydus Wellness eyes acquisitions in W. Asia, Africa
Looks at promising brands in skin care, hair care and health foods categoryDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramanbhai B Patel HUFDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pankaj Ramanbhai Patel HUFDisclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011
With reference to the captioned subject, please find enclosed the following two disclosures under regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011: 1. Sale of 533 Equity Shares of Rs. 10/- each by Ramanbhai B. Patel (HUF), Promoter Group, in open market and 2. Purchase of 533 Equity Shares of Rs. 10/- each by Pankaj Ramanbhai Patel (HUF), Promoter Group, from open market.Zydus gets USFDA final nod to mkt drugs for stomach ailments such as ulcer
The drug is also used to for preventing stomach bleeding in very ill patentsUpdates
Change in authority for making Disclosures under Regulation 30 [5] of SEBI (Listing Obligation and Disclosure Requirements), 2015